Although tubular retractor systems have gained popularity for other indications, there have been few reports of their use for arteriovenous malformation (AVM) surgery. A patient was diagnosed with a ruptured 1.2-cm subcortical AVM after presenting with intracerebral hemorrhage in the right frontal lobe and anterior basal ganglia. The characteristics of this AVM made it amenable to resection using a tubular retractor. OBJECTIVE: To demonstrate the feasibility and safety of AVM resection using a tubular retractor system. METHODS: Resection of the ruptured 1.2-cm subcortical AVM was performed utilizing the BrainPath TM (NICO corp, Indianapolis, Indiana) tubular retractor system. RESULTS: The BrainPath TM approach provided sufficient visualization and surgical freedom to permit successful AVM resection and hematoma evacuation. Postoperative imaging demonstrated near total hematoma removal and angiographic obliteration of the AVM. There were no complications, and the patient made an excellent recovery. CONCLUSION: Tubular retractors warrant consideration for accessing small, deep, ruptured AVMs. The nuances of such systems and their role in AVM surgery are discussed.
S
ubcortical lesions are among the most challenging for the neurosurgeon to access. Deep intra-axial lesions may require traversing cortex and white matter tracts, which can lead to neurological injury. Tubular reztractor systems have emerged as an important tool to enhance access to the subcortical space while minimizing disruption of overlying tissue. Reported applications of such systems have included mainly intracerebral hemorrhage (ICH) and deep intra-axial tumors, and its use for arteriovenous malformation (AVM) surgery has been limited. We report the use of the BrainPath TM (NICO Corp, Indianapolis, Indiana) tubular retractor system ABBREVIATIONS: ACA, anterior cerebral artery; ALIC, anterior limb of the internal capsule; AVM, arteriovenous malformation; CT, computed tomography; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage; NIH, National Institutes of Health; SLF, superior longitudinal fasciculus Supplemental digital content is available for this article at www.operativeneurosurgery-online.com.
to provide access for the resection of a ruptured subcortical AVM. The BrainPath TM system is an FDA-approved device for providing subcortical access to vascular abnormalities/malformations and other lesions. To the best of our knowledge, this is the first reported case of planned AVM resection using this retractor system.
Presentation and Evaluation
A 45-yr-old male presented with acute onset headache and multiple partial seizures. His past medical history was significant for hypertension, dyslipidemia, and multiple sclerosis. Upon arrival to the emergency department, he was alert with normal orientation and language and had left hemiparesis. Computed tomography (CT) of the head without contrast demonstrated ICH involving the right basal ganglia and deep right frontal white matter and a small amount of adjacent intraventricular hemorrhage (IVH; Figure 1 ).
The patient was admitted to the neurological intensive care unit for close monitoring and strict control of his blood pressure. stroke score was 11. CT angiography demonstrated a subtle cluster of abnormal vessels along the medial edge of the hematoma, adjacent to the anterior edge of the frontal horn of the right lateral ventricle (Figure 2 ). He underwent a diagnostic cerebral angiogram that showed a 1.2-cm AVM adjacent to the anterior right lateral ventricle ( Figure 3 ). Arterial input was from the right anterior cerebral artery (ACA), and venous drainage was via a prominent vein that traveled posteriorly toward the vein of Galen. The Spetzler-Martin grade 1 was III (nidus <3 cm, eloquent location, and deep venous drainage), and the supplementary AVM grade 2 was III (age >40, hemorrhagic presentation, and compact nidus). Continuous EEG (electroencephalography) monitoring revealed a nonclinical seizure originating from the right frontal region. There were no further seizures after 2 antiepileptic drugs were initiated, and his left hemiparesis gradually improved.
METHODS
Written informed consent was provided by the patient's surrogate. IRB approval was not required for a single case report. AVM resection using a BrainPath TM -mediated (NICO corp) transulcal approach was planned. A volumetric magnetic resonance image with contrast was obtained to plan the optimal trajectory ( Figure 4 ). Eight days after admission, the patient underwent surgery to resect the AVM. After general anesthesia was induced, the patient was positioned supine with the head turned slightly to the left and secured in 3-point fixation.
The frameless stereotactic navigation system was registered and used to locate the entry point, which was located in the right frontal region at the superior temporal line, approximately 2 cm superior and 2 cm posterior to the keyhole. A curvilinear frontotemporal incision was made just behind the hairline. The temporalis muscle was incised and the myocutaneous flap was reflected anteriorly in the submuscular plane. A 4.0-cm circular craniotomy centered over the entry point was made. A 1.5-cm cruciate dural opening was made over the entry point, which exposed the inferior frontal sulcus. The arachnoid over the sulcus was opened sharply and dissected over a short distance to allow for entrance of the tip of the tubular retractor into the sulcus. Using stereotactic navigational guidance, a 50-mm BrainPath TM sheath with obturator was advanced through the sulcal entry point along the planned trajectory and stopped just before reaching the AVM nidus. The obturator was removed, and the microscope was introduced, revealing a subacute hematoma ( Figure 5A ). The hematoma was removed with gentle aspiration revealing the AVM nidus, which was adjacent to the ependymal surface of the frontal horn ( Figure 5B ). Circumferential dissection was performed around the margin of the nidus, using suction, bipolar coagulation, and microscissors. Multiple small feeding arteries along the medial margin were coagulated and divided ( Figure 5C ). The ventricle was opened to provide access to the posterior margin of the nidus, revealing a single large draining vein exiting the posterior edge of the nidus and travelling posteriorly within the ventricle ( Figure 5D ). After the nidus had been dissected circumferentially, the only remaining point of attachment was this draining vein, which was subsequently coagulated and divided ( Figure 5E ). The nidus was removed en bloc. The cavity was irrigated and careful inspection revealed adequate hemostasis. The BrainPath TM sheath was removed slowly while inspecting the brain tissue along the walls to verify that there was no residual hematoma or AVM and no active bleeding.
RESULTS
The BrainPath TM sheath (NICO corp) facilitated resection of the AVM by providing sufficient visualization and surgical freedom, which is demonstrated in Video, Supplemental Digital Content. After the sheath was removed, there was minimal disruption of the overlying brain tissue ( Figure 5F ). A postoperative angiogram revealed no residual AVM nidus or arteriovenous shunting (Figure 6 ), and CT demonstrated near total hematoma removal and minimal disruption of surrounding brain tissue ( Figure 7 ). There were no perioperative complications. The patient was doing well at a 6-wk follow-up visit, with no focal neurological deficit. He has no significant disability, and his seizures remain well controlled.
DISCUSSION
Brain AVM rupture is associated with significant morbidity. Previous rupture is the strongest risk factor, and the annual risk of hemorrhage is approximately 2.2% annually if unruptured and 4.5% if ruptured. 3 AVM treatment is aimed at reducing the longterm hemorrhage risk, and the decision to treat is best made on a case-by-case basis depending on patient-and lesion-specific factors. Treatment options include radiosurgery, transcatheter embolization, resection, and combinations of these. Of these options, surgical resection leads to the highest probability of angiographic obliteration, provides the greatest protection from future hemorrhage, 4, 5 and has an immediate protective effect. A multimodality approach has been recommended for SpetzlerMartin grade III AVMs. 6 Our recommendation for surgical resection in this case was based on the angioarchitectural features and hemorrhagic presentation. We did not feel that observation OPERATIVE NEUROSURGERY or radiosurgery were optimal treatments for this lesion because it was recently ruptured and therefore at higher risk for rupture with observation or during the latency period that precedes radiosurgical obliteration. The potential surgical morbidity was reasonable given the small size, compact shape, and the presence of an adjacent hematoma. Grade III AVMs were associated with a 16% risk of neurological decline or death in Spetzler's series. 1 However, according to Lawton's subclassification of grade III AVMs, this lesion belongs to the lowest risk subtype for microsurgical resection (III-, or S1V1E1), with only 2.9% surgical morbidity. 7 Preoperative embolization is a useful adjunct to make resection safer for some AVMs. In the present case, embolization was not pursued because the angiographic appearance was not suggestive of a high-flow lesion, and the feeding arteries originating from the ACA were too small to permit selective catheterization.
Most supratentorial AVMs are based on a pial surface, and the craniotomy and surgical approach are designed to provide access to this surface, from which resection commences. The approach to subcortical AVMs is more complex and may require the surgeon to make a corticectomy and traverse normal brain tissue before reaching the lesion. This provides a narrow working corridor that requires retraction of the overlying brain tissue to provide adequate visualization. One common retraction strategy is to use a fixed blade retractor system. Alternatively, one can employ dynamic retraction with the surgical instruments (eg, suction and bipolar forceps) applied intermittently to the brain. More recently, tubular retractor systems have emerged as an alternative. The first intracranial tubular retractor system described by Kelly and colleagues 8 was affixed to a stereotactic frame. Other descriptions of tubular retractors have involved spinal retractor systems adapted for intracranial use [9] [10] [11] [12] [13] and retractors constructed from materials commonly available in the operating room. [14] [15] [16] [17] [18] [19] There are now commercially available cylindrical plastic retractor systems specifically designed for intracranial use. The BrainPath TM tubular retractor system (NICO corp) has emerged as a valuable tool for providing safe and efficient access to subcortical lesions. The system consists of a disposable clear plastic sheath and a reusable obturator. The obturator fits within the sheath and has a tapered end with an atraumatic tip. After opening the arachnoid over the sulcal entry point, the obturator and sheath are advanced as a unit through the brain tissue using stereotactic navigation. Once the target is reached, the obturator is removed, leaving the sheath in place to maintain the operative corridor. The sheath has an inner diameter of 13.5 mm and is available in lengths of 50, 60, and 75 mm.
Reported uses of the BrainPath TM system have included primarily spontaneous ICH 20-24 and brain tumors. 21, 25 Other applications include traumatic ICH, 26 cavernomas, 27-29 a ruptured periventricular aneurysm, 30 brain abscess, 21 and radiation necrosis. 31 The case series of BrainPath TM -mediated ICH evacuation by Labib and colleagues 24 included 2 cases in which AVMs were successfully removed using BrainPath TM . However, these previously unknown AVMs were discovered at the time of surgery after negative CT angiograms, and the authors did not recommend the use of BrainPath TM for the routine resection of AVMs. 24 While there have also been case reports of brain AVM resection using other tubular retractor systems, 13, 16 
FIGURE 7. Postoperative CT of the brain without contrast shows near complete removal of the hematoma and minimal disruption of brain tissue.
ours is the first reported case of planned AVM resection using BrainPath TM . AVM surgery follows a commonly accepted sequence of steps, beginning with exposure and identification of the main sites of arterial input and venous drainage. Resection of the nidus begins with disruption of arterial input, followed by circumferential dissection, and ligation of major draining veins allows for the ultimate disconnection and removal of the dearterialized nidus. AVM resection using BrainPath TM follows these same principles but requires consideration of some additional principles to provide optimal results. BrainPath TM requires a craniotomy approximately 3 cm in diameter, while the dural opening should be smaller (1.5 cm). This configuration provides a dural cuff that stabilizes the sheath, leaves the unexposed brain protected by dura, and leaves ample extradural space for manipulation of the sheath that is not restricted by bone. When using BrainPath TM , a transulcal approach is preferable because it requires less disruption of brain tissue compared to entering the cortex through a gyrus. In our experience, the tapered end and blunt tip of the obturator function to open the sulcus in atraumatic fashion so that minimal arachnoidal dissection is required prior to introducing the device. The surgeon must determine the appropriate depth for initial introduction of the sheath. For evacuation of ICH, we find it most useful to cannulate to the deep margin of the hematoma and OPERATIVE NEUROSURGERY work from the inside out. For an AVM, however, shallow cannulation is necessary. An ideal target for initial cannulation would be slightly superficial to the near margin of the nidus, in order to avoid violating the nidus before visualizing it. For this resection, we utilized a fine-tip suction, bipolar forceps, and bayoneted microscissors. We found that the BrainPath TM sheath allowed for ample room for bimanual operation using these instruments, while providing excellent visualization. In the event of difficult operating conditions, the BrainPath TM -mediated corridor could easily be converted to a larger corridor using an alternative retractor system. For this reason, we used a 4-cm craniotomy, which is slightly larger than we would typically employ for ICH evacuation.
Trajectory planning is a core element of the BrainPath TM approach. The ideal trajectory should minimize disruption of white matter tracts. For this lesion involving the posterior frontobasal region and anterior basal ganglia, important nearby tracts include the inferior fronto-occipital fasciculus, uncinate fasciculus, anterior limb of the internal capsule (ALIC), and superior longitudinal fasciculus (SLF). [33] [34] [35] Selecting a trajectory that lies sufficiently anterior within the frontal lobe should spare the uncinate fasciculus, ALIC, and SLF. In addition to avoiding these white matter tracts, our trajectory ( Figure 4 ) avoided eloquent cortex at the entry point, provided a relatively short operative corridor, was posterior enough to allow for a unilateral incision behind the hairline, and facilitated evacuation of the hematoma before encountering the nidus.
There are a few characteristics of this AVM that made it amenable to resection using the BrainPath TM technique. These include its small size, compact nidus shape, and arterial input from only a few small-caliber feeding arteries that were surgically accessible. Employing small angular movements of the sheath, we were easily able to reach all surfaces of the nidus and to coagulate and divide the feeding vessels. A large AVM would be more difficult to attack using BrainPath TM , as it would require large angular movements of the sheath and would provide visualization of only a small portion of the nidus at a time. This is in contrast to ICH and tumors, which can be debulked from within, allowing the peripheral portions of the lesion to fall into the field. Resection of this AVM was also aided by the fact that it had ruptured. Rupture status is a favorable factor for resection because in addition to minimizing the risk of causing a postoperative neurological decline, the hematoma can dissect a plan between the nidus and functional brain tissue and create a cavity around the nidus that minimizes the need for brain retraction. 32 In this case, evacuation of the hematoma through the BrainPath TM sheath was easily performed and provided a generous cavity at the depth of the sheath that provided immediate exposure of the anterior and lateral surface of the nidus.
Limitations
There are a few limitations to using BrainPath TM for AVM resection. Although BrainPath TM provided excellent access for resection of this particular AVM, it must be emphasized that this was a highly selected case that was amenable to BrainPath TMmediated resection for the reasons listed above. However, AVMs that are appropriate for this technique are likely rare, and standard microsurgical techniques should remain the treatment of choice for the majority of AVMs. The small diameter of the sheath, although sufficient for the introduction of 2 instruments while maintaining proper visualization, provides little excess space for an assistant surgeon to perform tasks such as suction or retraction. Fortunately, such assistance was not necessary in this case due to the small lesion size and minimal amount of bleeding encountered, but we would not recommend utilizing BrainPath TM for AVMs that are large or appear to have high flow. Furthermore, there is a learning curve associated with this technique, and we recommend that surgeons should refine their technique with less complex cases (eg, ICH) before using BrainPath TM to resect an AVM.
CONCLUSION
We have reported the successful planned resection of a ruptured subcortical AVM utilizing the BrainPath TM tubular retractor system (NICO corp). This system provided adequate visualization and surgical freedom for circumferential dissection around the AVM nidus and removal of the adjacent ICH, with minimal disruption of the overlying brain tissue. We propose that tubular retractor systems may be considered when accessing small, deep, ruptured AVMs. Their utility for unruptured lesions is uncertain, and standard cranial approaches should continue to be used for medium and large AVMs.
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